Propranolol in Hyperthyroidism: Symptomatic Control While Awaiting Definitive Treatment

Introduction to Propranolol Use

The American College of Cardiology recommends propranolol to rapidly control adrenergic symptoms, such as tachycardia, tremor, nervousness, and sweating, in hyperthyroidism while waiting for definitive treatments to normalize thyroid function 1

Propranolol blocks peripheral adrenergic effects of excess thyroid hormone, controlling tachycardia, tremor, anxiety, and sweating 1
Propranolol reverses abnormal vascular resistance seen in thyrotoxicosis 1

Propranolol serves as adjunctive therapy only—never as monotherapy—and must always be combined with definitive treatment, according to the American Thyroid Association 1
The American Thyroid Association recommends propranolol for immune checkpoint inhibitor-induced thyrotoxicosis, which typically represents transient thyroiditis that resolves spontaneously to hypothyroidism within weeks, requiring only supportive beta-blocker therapy without antithyroid drugs 1

Atenolol 100-200 mg daily is effective for patients with reactive airway disease, mild asthma, or intolerable CNS side effects from propranolol, as suggested by the European Thyroid Association 1

The American Heart Association advises against using propranolol in patients with high-degree AV block without pacemaker 1
The American Heart Association recommends avoiding propranolol in patients with severe bradycardia at baseline 1

The Endocrine Society suggests always starting steroids before thyroid hormone replacement to avoid precipitating adrenal crisis in patients with concurrent adrenal insufficiency and hypothyroidism 2

The American Association of Clinical Endocrinologists recommends rechecking thyroid function every 2-3 weeks after initiating treatment to catch the transition from hyperthyroidism to hypothyroidism 1, 2
The American Thyroid Association advises initiating levothyroxine replacement promptly when TSH rises and free T4 falls into hypothyroid range 2

The American College of Cardiology recommends continuing beta-blockers until euthyroid state is achieved, as cardioversion attempts often fail while thyrotoxicosis persists 1
Propranolol reduces the risk of failed cardioversion by normalizing thyroid function before attempting rhythm conversion, according to the Heart Rhythm Society 1